Postural myoclonus induced by phenytoin

Clinical Neuropharmacology

Volumn 19, Issue 6, 1996, Pages 536-538

  Duarte, J ^a   Sempere, A P ^a   Cabezas, M C ^a   Marcos, J ^a   Claveria L E ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Drug; Movement disorders; Phenytoin; Postural myoclonus

Indexed keywords

PHENYTOIN;

AGED; ARTICLE; BASAL GANGLION; CASE REPORT; DRUG INDUCED DISEASE; FLAPPING TREMOR; HUMAN; INVOLUNTARY MOVEMENT; MALE; MOTOR DYSFUNCTION; MYOCLONUS; PARKINSONISM; POSTURAL DRAINAGE; PRIORITY JOURNAL;

EID: 0029821460     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619060-00009     Document Type: Article

References (15)

1. Kooiker JC, Sumi SM. Movement disorder as a manifestation of diphenylhydantoin intoxication. Neurology 1974;1:68-71.
2. Eldridge R, Stern R, Livanainen M, Koerber T, Wilder BJ. "Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983;2:838-42.
3. Harrison MB, Lyons GR, Landow ER. Phenytoin and dyskinesias: a report of two cases and review of the literature. Mov Disord 1993;8:19-27.
4. Goni M, Jimenez M, Feijoo M. Parkinsonism induced by phenytoin. Clin Neuropharmacol 1985;8:383-4.
5. Lalonde R. Dopaminergic supersensitivity after long-term administration of phenytoin in rats. Epilepsia 1985;26:81-4.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
7. Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth Scientific, 1982:196-248.
8. Myers GJ. The therapy of myoclonus. In: Charlton MH, ed. Myoclonic seizures. Princeton: Excerpta Medica, 1975:121-60.
9. Pranzatelli MR, Snodgrass SR. The pharmacology of myoclonus: review. Clin Neuropharmacol 1985;8:99-130.
10. Korf J, Van Praag HM. Amine metabolism in the human brain. Further evaluation of the prohenecid test. Brain Res 1971;35:221-30.
11. Woodbury DM. Antiepileptic drugs. Phenytoin: proposed mechanisms of anticonvulsant action. In: Glaser GH, Penry JK, Woodhury DM. eds. Antiepileptic drugs: mechanisms of action. New York: Raven Press, 1980:447-71.
12. Hadfield MG. Uptake and binding of catecholamines. Effect of diphenylhydantoin and a new mechanism of action. Arch Neurol 1972;26:78-84.
13. Luhdorf K, Lund M. Phenyloin-induced hyperkinesia. Epilepsia 1977;18:409-15.
14. Mendez JS, Cotzias GC, Mena I, Papavasiliou PS. Diphenylhydantoin. Blocking of levodopa effects. Arch Neurol 1975;32:44-6.
15. Shaywitz BA, Cohen DJ, Bowers MB. Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology 1975;25:72-9.